South Korea’s IP-backed lending market growth exceeds targets
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min
The global scientific and engineering consultancy has bought TechPats, a patent-focused technical expert firm, at a time when an uncertain economy and declining number of M&As has led some companies to issue layoff notices to IP staff
After establishing an office in Asia, the CEO of the International Valuation Standards Council expands on plans to escalate intangible assets valuation in the region
26 July 2022
After over a decade and the involvement of various stakeholders, China achieved $46 billion in IP financing in 2021
08 July 2022
The partnership is aimed at helping the pharma giant to moentise deprioritised IP in the autoimmune space
04 July 2022
Although various government-led programmes have emerged over the years to encourage activity in the field, writes Joyce Ng, professionals reveal that a lack of transaction data and an absence of corporate buy-in is preventing it from going mainstream
22 June 2022
GE’s Licensing group participates in traditional patent licensing while also exploring new models like equity management
20 June 2022
Buyers should position themselves for opportunities as worsening economy spurs monetisation efforts, says Marc Booth
16 June 2022
Despite the close attentions of a tornado and the deadening heatwave that preceded and followed it, delegates and speakers in Chicago were in good form for the final day of this year's event
15 June 2022
Day Two of IPBC Global 2022 provided a succession of important contributions from some of the market’s most prominent thought-leaders
14 June 2022
University that secured over $200 million in a patent infringement suit against the South Korean giant has yet to see any of the cash
10 June 2022
Affinivax acquisition based on platform tech licensed from Boston Children’s Hospital
06 June 2022
Unlock unlimited access to all IAM content